Data from the NAVIGATE trial presented at EASL 2026 (May 27–30, Barcelona) oral presentation demonstrates belapectin reduces varices development ...
Galectin Therapeutics Inc. (NASDAQ:GALT), a clinical-stage biotechnology company developing therapeutics that target galectin-3 for patients with MASH cirrhosis and portal hypertension, today ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Repeated damage to the liver can cause scar tissue to gradually accumulate inside the organ. This condition, called cirrhosis ...
Spleen stiffness measurement (SSM) offers a noninvasive method to diagnose portal hypertension in BCR::ABL1-negative MPN patients, potentially improving patient management. SSM captures hepatic ...
MASH patients exhibit a higher spleen-to-liver stiffness ratio than ALD patients, indicating a presinusoidal component in portal hypertension. The study found that MASH patients have larger spleen ...
Chinese Medical Journals Publishing House Co., Ltd. Portal hypertension, a life-threatening complication of cirrhosis affecting millions globally, has seen paradigm shifts with the release of the ...
Pediatric hypertension is a significant concern because it can persist into adulthood and contribute to cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results